← Back to headlines
Amylyx Pharmaceuticals Prices Upsized $500M Public Offering
Amylyx Pharmaceuticals has priced an upsized public offering of common stock, aiming to raise $500 million.
20 Aug, 07:11 — 20 Aug, 07:11
Sources
Showing 1 of 1 sources
Amylyx Pharmaceuticals has priced an upsized public offering of common stock, aiming to raise $500 million.
